In a significant health safety measure, the Kerala government has imposed a ban on the sale and distribution of the ‘Coldrif’ cough syrup. This decision comes in the wake of multiple child deaths reported in Madhya Pradesh and Rajasthan, which have been linked to the consumption of this syrup.

The tragic incidents affected children who had been prescribed ‘Coldrif’ for common cold and cough symptoms. Subsequent investigations revealed that certain batches of the syrup contained a dangerous chemical known as diethylene glycol, a toxic industrial substance which can cause acute kidney failure and death.

The ban aims to prevent any further health risks to children across Kerala. Authorities have initiated sampling and testing of cough syrups available in the market to ensure public safety. Medical experts and the state health department have also issued warnings to parents and healthcare providers to refrain from using unapproved medications and to report any adverse effects immediately.

This ban follows similar actions taken by Madhya Pradesh and Rajasthan, where swift government intervention followed the detection of contaminated syrup batches. The central health ministry has also issued advisories against the use of cough syrups, particularly in children below two years of age.

The Kerala ban on ‘Coldrif’ is a critical step to safeguard public health and restore confidence in the medicine supply chain amid growing concerns about pharmaceutical regulation in India.